(CBRE) CBRE - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US12504L1098
Stock: Real Estate, Investment Management, Property Management, Consulting
Total Rating 34
Risk 73
Buy Signal -0.95
| Risk 5d forecast | |
|---|---|
| Volatility | 34.4% |
| Relative Tail Risk | -12.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.11 |
| Alpha | -20.79 |
| Character TTM | |
|---|---|
| Beta | 1.021 |
| Beta Downside | 1.346 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.04% |
| CAGR/Max DD | 0.79 |
EPS (Earnings per Share)
Revenue
Description: CBRE CBRE March 02, 2026
CBRE Group, Inc. (NYSE: CBRE) is the world’s largest commercial real-estate services firm, delivering advisory, property management, facilities-management, and investment-management solutions across office, industrial, retail, data-center, and specialized facilities. Its operations are organized into four segments: Advisory Services (leasing, sales, financing, valuation, and consulting), Building Operations & Experience (facility and day-to-day management), Project Management (via Turner & Townsend), and Real Estate Investments (institutional investment management and development under the Trammell Crow brand).
Key recent metrics underscore CBRE’s scale and market positioning: FY 2023 revenue reached $27.8 billion, a 6 % YoY increase, while adjusted earnings per share rose to $6.49. The firm’s global office vacancy rate climbed to roughly 15 % in Q4 2023, pressuring leasing activity, whereas industrial vacancy fell to under 5 % driven by sustained e-commerce demand. Rising interest rates have widened cap rates, prompting investors to seek higher-yield assets such as logistics and data-center properties-segments where CBRE’s investment platform has seen a 12 % inflow increase year-to-date.
For a deeper dive into CBRE’s valuation and how these trends may affect its outlook, consider exploring ValueRay’s analysis.
Headlines to watch out for
- Commercial real estate transaction volume impacts Advisory Services revenue
- Global economic slowdown reduces demand for office and retail space
- Interest rate hikes affect real estate investment and development
- Facilities management contracts provide stable recurring revenue
- Valuation and consulting services sensitive to market volatility
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.16b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.26 > 1.0 |
| NWC/Revenue: 2.88% < 20% (prev 1.91%; Δ 0.97% < -1%) |
| CFO/TA 0.05 > 3% & CFO 1.56b > Net Income 1.16b |
| Net Debt (8.13b) to EBITDA (2.49b): 3.27 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (299.9m) vs 12m ago -2.74% < -2% |
| Gross Margin: 35.88% > 18% (prev 0.20%; Δ 3568 % > 0.5%) |
| Asset Turnover: 146.8% > 50% (prev 146.7%; Δ 0.08% > 0%) |
| Interest Coverage Ratio: 9.51 > 6 (EBITDA TTM 2.49b / Interest Expense TTM 185.0m) |
Altman Z'' 2.16
| A: 0.04 (Total Current Assets 13.49b - Total Current Liabilities 12.32b) / Total Assets 30.88b |
| B: 0.32 (Retained Earnings 9.92b / Total Assets 30.88b) |
| C: 0.06 (EBIT TTM 1.76b / Avg Total Assets 27.63b) |
| D: 0.42 (Book Value of Equity 8.88b / Total Liabilities 21.25b) |
| Altman-Z'' Score: 2.16 = BBB |
Beneish M -3.28
| DSRI: 1.15 (Receivables 10.55b/8.10b, Revenue 40.55b/35.77b) |
| GMI: 0.54 (GM 35.88% / 19.55%) |
| AQI: 0.92 (AQ_t 0.46 / AQ_t-1 0.50) |
| SGI: 1.13 (Revenue 40.55b / 35.77b) |
| TATA: -0.01 (NI 1.16b - CFO 1.56b) / TA 30.88b) |
| Beneish M-Score: -3.28 (Cap -4..+1) = AA |
What is the price of CBRE shares?
As of March 09, 2026, the stock is trading at USD 136.83 with a total of 2,139,727 shares traded.
Over the past week, the price has changed by -5.61%, over one month by -19.97%, over three months by -11.94% and over the past year by +8.66%.
Over the past week, the price has changed by -5.61%, over one month by -19.97%, over three months by -11.94% and over the past year by +8.66%.
Is CBRE a buy, sell or hold?
CBRE has received a consensus analysts rating of 4.08.
Therefore, it is recommended to buy CBRE.
- StrongBuy: 5
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CBRE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 181.6 | 32.7% |
| Analysts Target Price | 181.6 | 32.7% |
CBRE Fundamental Data Overview March 04, 2026
P/E Trailing = 37.557
P/E Forward = 20.3666
P/S = 1.0639
P/B = 4.8197
P/EG = 0.8598
Revenue TTM = 40.55b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 2.49b USD
Long Term Debt = 5.05b USD (from longTermDebt, last quarter)
Short Term Debt = 2.82b USD (from shortTermDebt, last quarter)
Debt = 9.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.13b USD (from netDebt column, last quarter)
Enterprise Value = 51.27b USD (43.14b + Debt 9.99b - CCE 1.86b)
Interest Coverage Ratio = 9.51 (Ebit TTM 1.76b / Interest Expense TTM 185.0m)
EV/FCF = 42.97x (Enterprise Value 51.27b / FCF TTM 1.19b)
FCF Yield = 2.33% (FCF TTM 1.19b / Enterprise Value 51.27b)
FCF Margin = 2.94% (FCF TTM 1.19b / Revenue TTM 40.55b)
Net Margin = 2.85% (Net Income TTM 1.16b / Revenue TTM 40.55b)
Gross Margin = 35.88% ((Revenue TTM 40.55b - Cost of Revenue TTM 26.00b) / Revenue TTM)
Gross Margin QoQ = 15.29% (prev 19.40%)
Tobins Q-Ratio = 1.66 (Enterprise Value 51.27b / Total Assets 30.88b)
Interest Expense / Debt = 0.27% (Interest Expense 27.0m / Debt 9.99b)
Taxrate = 20.21% (114.0m / 564.0m)
NOPAT = 1.40b (EBIT 1.76b * (1 - 20.21%))
Current Ratio = 1.09 (Total Current Assets 13.49b / Total Current Liabilities 12.32b)
Debt / Equity = 1.13 (Debt 9.99b / totalStockholderEquity, last quarter 8.88b)
Debt / EBITDA = 3.27 (Net Debt 8.13b / EBITDA 2.49b)
Debt / FCF = 6.81 (Net Debt 8.13b / FCF TTM 1.19b)
Total Stockholder Equity = 8.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.19% (Net Income 1.16b / Total Assets 30.88b)
RoE = 13.63% (Net Income TTM 1.16b / Total Stockholder Equity 8.49b)
RoCE = 12.99% (EBIT 1.76b / Capital Employed (Equity 8.49b + L.T.Debt 5.05b))
RoIC = 8.98% (NOPAT 1.40b / Invested Capital 15.62b)
WACC = 7.90% (E(43.14b)/V(53.13b) * Re(9.68%) + D(9.99b)/V(53.13b) * Rd(0.27%) * (1-Tc(0.20)))
Discount Rate = 9.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.41%
[DCF] Terminal Value 79.42% ; FCFF base≈1.31b ; Y1≈1.41b ; Y5≈1.70b
[DCF] Fair Price = 74.78 (EV 30.20b - Net Debt 8.13b = Equity 22.07b / Shares 295.2m; r=7.90% [WACC]; 5y FCF grow 7.89% → 2.90% )
EPS Correlation: 23.44 | EPS CAGR: 19.72% | SUE: 0.89 | # QB: 6
Revenue Correlation: 88.47 | Revenue CAGR: 13.08% | SUE: -1.47 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.49 | Chg7d=+0.010 | Chg30d=+0.011 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-12-31): EPS=7.50 | Chg7d=-0.009 | Chg30d=+0.018 | Revisions Net=+1 | Growth EPS=+17.5% | Growth Revenue=+12.4%
EPS next Year (2027-12-31): EPS=8.70 | Chg7d=-0.089 | Chg30d=-0.028 | Revisions Net=+3 | Growth EPS=+16.0% | Growth Revenue=+9.0%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.0% (Discount Rate 9.7% - Earnings Yield 2.7%)
[Growth] Growth Spread = +6.3% (Analyst 13.4% - Implied 7.0%)
P/E Forward = 20.3666
P/S = 1.0639
P/B = 4.8197
P/EG = 0.8598
Revenue TTM = 40.55b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 2.49b USD
Long Term Debt = 5.05b USD (from longTermDebt, last quarter)
Short Term Debt = 2.82b USD (from shortTermDebt, last quarter)
Debt = 9.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.13b USD (from netDebt column, last quarter)
Enterprise Value = 51.27b USD (43.14b + Debt 9.99b - CCE 1.86b)
Interest Coverage Ratio = 9.51 (Ebit TTM 1.76b / Interest Expense TTM 185.0m)
EV/FCF = 42.97x (Enterprise Value 51.27b / FCF TTM 1.19b)
FCF Yield = 2.33% (FCF TTM 1.19b / Enterprise Value 51.27b)
FCF Margin = 2.94% (FCF TTM 1.19b / Revenue TTM 40.55b)
Net Margin = 2.85% (Net Income TTM 1.16b / Revenue TTM 40.55b)
Gross Margin = 35.88% ((Revenue TTM 40.55b - Cost of Revenue TTM 26.00b) / Revenue TTM)
Gross Margin QoQ = 15.29% (prev 19.40%)
Tobins Q-Ratio = 1.66 (Enterprise Value 51.27b / Total Assets 30.88b)
Interest Expense / Debt = 0.27% (Interest Expense 27.0m / Debt 9.99b)
Taxrate = 20.21% (114.0m / 564.0m)
NOPAT = 1.40b (EBIT 1.76b * (1 - 20.21%))
Current Ratio = 1.09 (Total Current Assets 13.49b / Total Current Liabilities 12.32b)
Debt / Equity = 1.13 (Debt 9.99b / totalStockholderEquity, last quarter 8.88b)
Debt / EBITDA = 3.27 (Net Debt 8.13b / EBITDA 2.49b)
Debt / FCF = 6.81 (Net Debt 8.13b / FCF TTM 1.19b)
Total Stockholder Equity = 8.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.19% (Net Income 1.16b / Total Assets 30.88b)
RoE = 13.63% (Net Income TTM 1.16b / Total Stockholder Equity 8.49b)
RoCE = 12.99% (EBIT 1.76b / Capital Employed (Equity 8.49b + L.T.Debt 5.05b))
RoIC = 8.98% (NOPAT 1.40b / Invested Capital 15.62b)
WACC = 7.90% (E(43.14b)/V(53.13b) * Re(9.68%) + D(9.99b)/V(53.13b) * Rd(0.27%) * (1-Tc(0.20)))
Discount Rate = 9.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.41%
[DCF] Terminal Value 79.42% ; FCFF base≈1.31b ; Y1≈1.41b ; Y5≈1.70b
[DCF] Fair Price = 74.78 (EV 30.20b - Net Debt 8.13b = Equity 22.07b / Shares 295.2m; r=7.90% [WACC]; 5y FCF grow 7.89% → 2.90% )
EPS Correlation: 23.44 | EPS CAGR: 19.72% | SUE: 0.89 | # QB: 6
Revenue Correlation: 88.47 | Revenue CAGR: 13.08% | SUE: -1.47 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.49 | Chg7d=+0.010 | Chg30d=+0.011 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-12-31): EPS=7.50 | Chg7d=-0.009 | Chg30d=+0.018 | Revisions Net=+1 | Growth EPS=+17.5% | Growth Revenue=+12.4%
EPS next Year (2027-12-31): EPS=8.70 | Chg7d=-0.089 | Chg30d=-0.028 | Revisions Net=+3 | Growth EPS=+16.0% | Growth Revenue=+9.0%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.0% (Discount Rate 9.7% - Earnings Yield 2.7%)
[Growth] Growth Spread = +6.3% (Analyst 13.4% - Implied 7.0%)